Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9137 |
High Similarity |
NPD1510 |
Phase 2 |
0.9048 |
High Similarity |
NPD4380 |
Phase 2 |
0.8811 |
High Similarity |
NPD1549 |
Phase 2 |
0.8767 |
High Similarity |
NPD1511 |
Approved |
0.8742 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8741 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8741 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8714 |
High Similarity |
NPD1240 |
Approved |
0.8693 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8675 |
High Similarity |
NPD1934 |
Approved |
0.8649 |
High Similarity |
NPD1512 |
Approved |
0.8618 |
High Similarity |
NPD2801 |
Approved |
0.8592 |
High Similarity |
NPD1607 |
Approved |
0.8581 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8542 |
High Similarity |
NPD2796 |
Approved |
0.8491 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8365 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8365 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8365 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8333 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8333 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8312 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8299 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8269 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8269 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8258 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.821 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8205 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8205 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8194 |
Intermediate Similarity |
NPD943 |
Approved |
0.816 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.816 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8146 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8121 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.811 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8105 |
Intermediate Similarity |
NPD5403 |
Approved |
0.8098 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8089 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8067 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.8061 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8041 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.8025 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8013 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8012 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7974 |
Intermediate Similarity |
NPD5401 |
Approved |
0.795 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7949 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7947 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7919 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7901 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7892 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7891 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7866 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7857 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7857 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7857 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7844 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7838 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7771 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7764 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7763 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7733 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7733 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7712 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7703 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7703 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7702 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7697 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7688 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7647 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7647 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7643 |
Intermediate Similarity |
NPD920 |
Approved |
0.7628 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7622 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7619 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7616 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7613 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7605 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7568 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7566 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7566 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7552 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7548 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7543 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7534 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7532 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD919 |
Approved |
0.7485 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7484 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7483 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.747 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7466 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7452 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.745 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7432 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7419 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7403 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7394 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7379 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7372 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7368 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7365 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7353 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7321 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7314 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.731 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7303 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7301 |
Intermediate Similarity |
NPD37 |
Approved |
0.7278 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7273 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7263 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7263 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7262 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7262 |
Intermediate Similarity |
NPD5711 |
Approved |
0.726 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7254 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7253 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7253 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7253 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7253 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7253 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7253 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7253 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7232 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.723 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7222 |
Intermediate Similarity |
NPD9268 |
Approved |
0.7222 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7216 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7215 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7204 |
Intermediate Similarity |
NPD7584 |
Approved |
0.72 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.72 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7197 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7195 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7192 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7192 |
Intermediate Similarity |
NPD1201 |
Approved |
0.719 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.719 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7188 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7186 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7169 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7169 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7169 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7161 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7159 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7143 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7143 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7135 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7128 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7126 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7125 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7117 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7105 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7105 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7105 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7101 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7095 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7078 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7076 |
Intermediate Similarity |
NPD2403 |
Approved |
0.707 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7063 |
Intermediate Similarity |
NPD3300 |
Phase 2 |
0.7048 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7048 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7043 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7043 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7043 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7033 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7033 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7025 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.702 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7012 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7006 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7006 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7006 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7006 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7006 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7006 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7005 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7005 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7 |
Intermediate Similarity |
NPD1164 |
Approved |
0.6994 |
Remote Similarity |
NPD7228 |
Approved |
0.6993 |
Remote Similarity |
NPD1296 |
Phase 2 |
0.6993 |
Remote Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.6993 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6993 |
Remote Similarity |
NPD411 |
Approved |
0.6989 |
Remote Similarity |
NPD6823 |
Phase 2 |
0.6984 |
Remote Similarity |
NPD7701 |
Phase 2 |
0.698 |
Remote Similarity |
NPD4749 |
Approved |
0.6978 |
Remote Similarity |
NPD6535 |
Approved |
0.6978 |
Remote Similarity |
NPD6534 |
Approved |
0.6975 |
Remote Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.6975 |
Remote Similarity |
NPD4662 |
Approved |
0.6975 |
Remote Similarity |
NPD4661 |
Approved |
0.6973 |
Remote Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.6968
|
Remote Similarity |
NPD1933 |
Approved |